AZD5423, AZD7594 and AZD9567 with high affinity to GR were in clinical trials for the therapy of chronic obstructive pulmonary disease (COPD) [72–74], asthma [75, 76] and rheumatoid arthritis [77], respectively. The gene discussed is NR3C1; the disease is asthma.